We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-12.1%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$9.31B
AUM Growth
-$2.18B
Cap. Flow
-$401M
Cap. Flow %
-4.31%
Top 10 Hldgs %
27.85%
Holding
345
New
63
Increased
99
Reduced
112
Closed
56

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$131M
2
NFLX icon
Netflix
NFLX
+$85.4M
3
LITE icon
Lumentum
LITE
+$78.4M
4
CRWD icon
CrowdStrike
CRWD
+$73.9M
5
AMZN icon
Amazon
AMZN
+$66.1M

Sector Composition

Rank Sector Weight
1 Technology 36.1%
2 Healthcare 19.51%
3 Financials 18.54%
4 Communication Services 10.44%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMED icon
101
Globus Medical
GMED
$10.7B
$26.8M 0.29%
+630,474
New +$31.1M
NVST icon
102
Envista
NVST
$4.44B
$26.1M 0.28%
+1,750,180
New +$44.8M
SRCL
103
DELISTED
Stericycle Inc
SRCL
$26M 0.28%
534,786
-184,262
-26% -$10.9M
PRNB
104
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$25.7M 0.28%
+432,846
New +$25.2M
RLI icon
105
RLI Corp
RLI
$5.62B
$25.6M 0.28%
583,000
USFD icon
106
US Foods
USFD
$22.2B
$25.5M 0.27%
1,438,720
+221,485
+18% +$7.42M
KEYS icon
107
Keysight
KEYS
$54.5B
$25.4M 0.27%
303,603
-142,707
-32% -$13.6M
DCPH
108
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$25.4M 0.27%
616,261
+140,777
+30% +$7.82M
SSNC icon
109
SS&C Technologies
SSNC
$18.1B
$24.9M 0.27%
568,842
-222,692
-28% -$12.6M
REGN icon
110
Regeneron Pharmaceuticals
REGN
$78.5B
$24.4M 0.26%
50,000
-45,223
-47% -$18.7M
OXFD
111
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$23.8M 0.26%
2,568,385
NSTG
112
DELISTED
NanoString Technologies, Inc.
NSTG
$23.3M 0.25%
969,120
+144,120
+17% +$4.17M
BLU
113
DELISTED
BELLUS Health Inc.
BLU
$23.3M 0.25%
2,330,893
-692,732
-23% -$6.17M
SGEN
114
DELISTED
Seagen Inc. Common Stock
SGEN
$23.1M 0.25%
200,000
+5,000
+3% +$554K
VRTX icon
115
Vertex Pharmaceuticals
VRTX
$121B
$22.6M 0.24%
95,000
-5,000
-5% -$1.15M
ICE icon
116
Intercontinental Exchange
ICE
$85.6B
$21.8M 0.23%
+269,822
New +$24.5M
ENSG icon
117
The Ensign Group
ENSG
$10.4B
$20.2M 0.22%
538,184
+161,964
+43% +$7.1M
JPM icon
118
JPMorgan Chase
JPM
$935B
$20.1M 0.22%
223,118
-274,076
-55% -$33.3M
JRVR icon
119
James River Group Holdings
JRVR
$208M
$19.9M 0.21%
550,000
+100,000
+22% +$4.03M
UBER icon
120
Uber
UBER
$143B
$19.5M 0.21%
698,386
-1,554,519
-69% -$51.2M
C icon
121
Citigroup
C
$222B
$19.5M 0.21%
462,018
-540,883
-54% -$36.3M
APTO
122
DELISTED
Aptose Biosciences, Inc.
APTO
$19M 0.2%
7,109
+5,665
+392% +$16.9M
ENOV icon
123
Enovis
ENOV
$1.68B
$18.6M 0.2%
545,607
+40,479
+8% +$2.23M
TXN icon
124
Texas Instruments
TXN
$252B
$18.5M 0.2%
184,773
+52,177
+39% +$6.26M
FAF icon
125
First American
FAF
$7.66B
$18.4M 0.2%
435,000
+60,000
+16% +$3.43M

Similar funds

Polar Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Polar Capital held 345 positions worth $9.31B, down 19% from $11.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Polar Capital withdrew a net $401M in Q1 2020, closing 56 positions and reducing 112 holdings. Its most notable exit was Aon, an estimated $69.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital opened a new position in Intel worth $120M.

  • Polar Capital's largest Q1 2020 buy was Intel: 2,214,788 shares worth $120M.
  • Polar Capital added most to Netflix in Q1 2020, an estimated $85.4M increase.
  • Polar Capital's biggest Q1 2020 reduction was Alphabet (Google) Class C, cutting an estimated $95M.
  • Polar Capital fully exited Aon in Q1 2020, selling an estimated $69.9M.
  • Polar Capital's ten largest holdings make up 28% of its $9.31B portfolio in Q1 2020.
  • Polar Capital opened 63 new positions and closed 56 in Q1 2020.
  • Polar Capital's portfolio value fell 19% quarter-over-quarter to $9.31B.

Based on Polar Capital's 13F filing for Q1 2020, filed 15 May 2020.